RA PHARMACEUTICALS, INC. Financing Cash Flow
RA PHARMACEUTICALS, INC. reported Financing Cash Flow of $143.40 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $1.24M, a 99.12% decline year-over-year.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was $141.57M, a 75204.79% increase year-over-year.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was $544.00K.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-03-31 was $42.00K, a 99.92% decline year-over-year.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2019 was $143.40M, a 26.62% decline from fiscal 2018.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2018 was $195.42M, a 25613.29% increase from fiscal 2017.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2017 was $760.00K, a 99.39% decline from fiscal 2016.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2016 was $125.24M, a 331.43% increase from fiscal 2015.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $142.81M derived: sum of 2 quarters · filed 2020-02-27 | $143.35M derived: sum of 3 quarters · filed 2020-02-27 | $143.40M 10-K · filed 2020-02-27 |
| 2019-09-30 | $141.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $142.12M derived: sum of 2 quarters · filed 2019-11-07 | $142.16M 10-Q · filed 2019-11-07 | $283.12M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $586.00K 10-Q · filed 2019-08-07 | $141.54M derived: sum of 3 quarters · filed 2020-02-27 | $141.73M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $42.00K 10-Q · filed 2019-05-09 | $141.00M derived: sum of 2 quarters · filed 2020-02-27 | $141.19M derived: sum of 3 quarters · filed 2020-02-27 | $141.18M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | $140.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $141.14M derived: sum of 2 quarters · filed 2020-02-27 | $141.13M derived: sum of 3 quarters · filed 2020-02-27 | $195.42M 10-K · filed 2020-02-27 |
| 2018-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $178.00K derived: sum of 2 quarters · filed 2019-11-07 | $54.47M 10-Q · filed 2019-11-07 | $54.43M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $54.28M 10-Q · filed 2019-08-07 | $54.24M derived: sum of 3 quarters · filed 2019-08-07 | $54.20M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $54.29M 10-Q · filed 2019-05-09 | $54.25M derived: sum of 2 quarters · filed 2019-05-09 | $54.21M derived: sum of 3 quarters · filed 2019-05-09 | $55.01M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$75.00K derived: sum of 2 quarters · filed 2019-03-07 | $719.00K derived: sum of 3 quarters · filed 2019-03-07 | $760.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $756.00K derived: sum of 2 quarters · filed 2018-11-07 | $797.00K 10-Q · filed 2018-11-07 | $97.05M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $794.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $835.00K 10-Q · filed 2018-08-08 | $97.08M derived: sum of 3 quarters · filed 2018-08-08 | $96.80M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $41.00K 10-Q · filed 2018-05-09 | $96.29M derived: sum of 2 quarters · filed 2018-05-09 | $96.00M derived: sum of 3 quarters · filed 2018-05-09 | |
| 2016-12-31 | $96.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $95.96M derived: sum of 2 quarters · filed 2018-03-14 | $125.24M 10-K · filed 2018-03-14 | |
| 2016-09-30 | -$285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $28.99M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $29.27M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $29.03M 10-K · filed 2018-03-14 |